logo-loader
viewC4X Discovery Holdings PLC

C4X Discovery Holdings PLC bags a billion molecules (virtually)

Drug discovery and development company C4X Discovery Holdings plc has bought a suite of advanced drug discovery technologies from the administrator that should prove highly complementary to the company’s existing know-how.
The company has acquired “a virtual library of over a billion molecules”, which should give the company a boost when it starts new discovery programmes.
According to Dr Clive Dix, the chief executive officer of C4X, the newly acquired software is “all about optimising those molecules that we find by using our other technologies”.
Dr Dix told Proactive Investors: “Everything we do is aimed at reducing the time and the cost of getting to the clinical trial and then … with the molecules we have being of higher quality, they’ll be more likely to be successful in the trials.”
The company will be starting new projects on a regular basis and when the time is right will decide on a case-by-case basis whether to bring in a partner or take the drugs to clinical trial independently.

Quick facts: C4X Discovery Holdings PLC

Price: 18.75 GBX

AIM:C4XD
Market: AIM
Market Cap: £22.35 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of C4X Discovery Holdings PLC named herein, including the promotion by the Company of C4X Discovery Holdings PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Morning Report: FTSE 100 on the up as airline stocks surge higher

Headlines from the Proactive UK newsroom. The FTSE 100 index rose again as airline stocks surged higher. British Airways owner IAG led the way climbing 11% in the morning while the index jumped 71 to 6,412. AstraZenecasays it will soon be able to supply two billion doses of a potential...

on 5/6/20

2 min read